Mass Spectrometry Market : Global Industry Analysis and Forecast 2029

Mass Spectrometry Market size reached USD 5.78 billion in 2022 and is expected to reach USD 9.41 billion by 2029 Mass Spectrometry, growing at a CAGR of 7.2% during the forecast period.

Mass spectrometry (MS) is one of the most powerful technologies for analyzing a wide range of chemical and biological components. The high demand and resulting requirements from the pharmaceutical and biotechnology sectors are the key factors for some extraordinary recent advances in mass spectrometry technology. The development of new techniques and software has the potential to increase the use of mass spectroscopy in drug development, proteomics, pharmaceuticals, food safety testing, and many other sectors. The need for life sciences applications has led to the advancement of MS technologies and the rapid development of new types of instruments.

Thermo Fisher Scientific, Inc. and Agilent Technologies are the two leading key players in the mass spectrometry market. Increased spending on pharmaceutical R&D across the globe, government regulations on drug safety, a growing focus on the quality of food products, a rise in crude and shale gas production, and growing government initiatives for pollution control and environmental testing are all high growth prospects for the market during the forecast period.To know about the Research Methodology :- Request Free Sample Report
Mass Spectrometry Market Dynamics:
Rising Adoption of Mass Spectrometers in the Food and Beverage Sector to Drive Demand for Mass Spectrometers

Consumers are becoming more interested in food and beverages, and they are demanding more assurances about the quality, safety, and geographical origin of the products that they consume. In this regard, global food safety authorities give various guidelines and rules to protect public health, as well as many scientific perspectives on the bioactive compounds found in foods, which have resulted in a significant change in food choices. Mass spectrometry is a versatile technology that may be used to analyze foods and beverages as well as food contact materials such as packaging. It has the unique benefits of high selectivity, sensitivity, and a fast response time. It allows for direct molecular characterization of a variety of raw food samples with minimal or no sample pre-treatment. It has been widely used in food science and industry because of its high sensitivity and specificity. Even in low concentrations, hazards ranging from heavy metals to pesticides and toxins may be identified using mass spectrometry.

The market in North America is growing due to the presence of key players, as well as increased activities by several organizations to produce and spread awareness about new advanced spectrometry techniques and products. The increased use of spectroscopic instruments in the food and beverage sector, as well as growing R&D activities in the field of biotechnology, are driving market growth in the region.



Technological Advancement in Mass Spectrometry

There is a rising demand for automation in diagnostic approaches as well as a cost-effective platform for sample analysis. This has motivated manufacturers to focus on product development and innovation. Technological advancements in mass spectrometer devices, as well as rising concerns about food safety around the world, are two major factors driving the growth of the mass spectrometry market. The key market players in the industry are always trying to improve their existing products and launch innovative and advanced mass spectrometer devices. Thermo Fisher Scientific introduced the Orbitrap Exploris 120 mass spectrometer in May 2020, with features such as fast scanning modes and rapid polarity switching. In addition, the companies engage in activities such as mergers and acquisitions, strategic partnerships, or collaboration to acquire or develop new technologies in the field.

Increased R&D Activities in the Biotech and Pharma Industries to Boost Market

Funding for the pharmaceutical and biotechnology industries has grown. This trend is expected to continue in the near future, as many current and emerging pharma and biotech companies focus on the research and development of innovative techniques and instruments like mass spectrometers. For instance, Ion Mobility Mass Spectrometry (IMS-MS) is rapidly gaining popularity for improving metabolomic, lipidomic, and proteomic analyses. Thus, an increase in R&D spending is likely to enhance global market demand for spectrometry. Companies invest in key areas such as customized medicine and biopharmaceuticals. They are also investing in innovative products such as mass

spectrophotometers. According to MMR, the medical and health research and development expenditure reached USD 267.1 billion in 2021. The mass spectrometry market is expected to grow over the forecast period as a result of the aforementioned factors. However, the high cost of mass spectroscopy equipment and a lack of skilled professionals may restrain the growth of the mass spectrometry market during the forecast period.



High cost associated with the Mass Spectrometry instruments

Spectrometry instruments are more expensive because they have more complicated features and functions. Aside from the system's purchase price, the cost of conforming the system to industry standards is also extremely high. The high capital investment required to install and maintain spectrometer devices is expected to hamper spectrometry market growth. Spectrometers are excessively costly in small diagnostic clinics and laboratories. Furthermore, technological advancements have resulted in rising instrument costs. The high cost of a spectrometer influences end users' purchasing decisions. Pharmaceutical companies require a huge number of these systems, which significantly raises the capital cost.
Mass Spectrometry Market Segment Analysis:
By Technology, the Hybrid Mass Spectrometry segment is expected to grow at the highest CAGR during the forecast period. Hybrid mass spectrometers are made up of at least two different types of "mass" analyzers arranged progressively from the ion source to the ion detector. Hybrid mass spectrometers combine several mass-analyzer components in the same quest for enhanced performance.

By Application, the life science research segment is expected to grow at a significant CAGR during the forecast period. Mass spectrometry techniques for investigating complex signatures of biomolecules have become important in molecular life science research. Various mass spectrometry-based omics technologies are now available to monitor qualitative and quantitative changes in hundreds or thousands of biologically active components, such as proteins/peptides, lipids, and metabolites. These comprehensive studies have the ability to explain the mechanism of disease development at the molecular level and to monitor the individual response to pharmacological therapy or lifestyle intervention. The rising application of omics technology in diagnostics and biomarker identification as well as growing R&d investment and government funding for proteomics is expected to increase the market for this segment.



By End Users, the Pharmaceutical industries are among the most important end-users of mass spectrometers. The instrument's increased sensitivity and resolution have opened up new perspectives in the analysis of medicines and complex metabolites of biological systems. The availability of government and corporate funding for pharmaceutical research, the rise of the pharmaceutical sector, and the existence of severe regulatory guidelines for drug development and safety are some of the important factors driving the growth of this segment during the forecast period.
Mass Spectrometry Market Regional Insights
The Mass Spectrometry Market is expected to be dominated by North America.

North America dominates the mass spectrometry market owing to increased investment in research and development, widespread use of mass spectrometer instruments in the life sciences, metabolomics, and petroleum sectors, as well as the presence of key market players in the region. The United States will have the biggest market share in North America for mass spectrometry because of significant government and private sector investment in research and development. Regulatory bodies in the United States such as the Food and Drug Administration (FDA) are also pushing for the use of analytical techniques to ensure that pharmaceutical items released to the market fulfill quality criteria. With new oil fields, the United States has witnessed a significant increase in shale gas and crude oil technology advances, resulting in an increase in the usage of analytical equipment such as mass spectrometers.

Asia Pacific's Mass Spectrometry market is expected to grow at the highest rate in the market due to the availability of a strong research foundation for new drug development. This is expected to increase the region's adoption of this technology. Because of the increase in the number of spectrometry service providers, Asian countries like China, Japan, and India have significantly contributed to market growth.

China's market is expected to grow at the highest rate owing to the availability of a robust research basis for new pharmaceutical development. An increase in the number of spectrometry service providers as well as various conferences and exhibitions conducted by manufacturers to promote spectrometry technology are all contributing to the spectrometer market's growth.

The Mass Spectrometry Market report forecasts revenue growth at global, and country levels and provides an analysis of the latest industry trends in each of the sub-segments during the forecast period. MMR has segmented the global Mass Spectrometry Market report based on Technology, Application, End-User, and region. The report contains strategic profiling of top key players in the market, a wide-ranging analysis of their core competencies, and their strategies like new product launches, growths, agreements, joint ventures, partnerships, and acquisitions that apply to the businesses. Our team of analysts can also provide you with data in excel files and pivot tables or can assist you in creating presentations from the data sets available in the report.
Mass Spectrometry Market Scope: Inquire before buying



Mass Spectrometry Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2017 to 2022
Market Size in 2022:
US $ 5.78 Bn.


Forecast Period 2023 to 2029 CAGR:
7.2 %
Market Size in 2029:
US 9.41 Bn.


 Segments Covered:
by Technology
1.Hybrid Mass Spectrometry
2.Single Mass Spectrometry


by Application
1.Life Science Research
2.Drug Discovery
3.Environmental Testing
4.Food Testing
5.Applied Industries
6.Clinical Diagnostics


by End-User
1.Pharmaceutical Industry
2.Biotechnology Industry
3.Research & Academic Institutes
4.Environmental Testing Industry
5.Food & Beverage Testing Industry
6.Petrochemical Industry



Mass Spectrometry Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Mass Spectrometry Market, Key Players are:
1.PerkinElmer, Inc.
2.Thermo Fisher Scientific
3. Danaher Corporation
4.Bruker Corporation
5.Agilent Technologies
6.Waters Corporation
7.Shimadzu Corporation
8.Bio-Rad Laboratories
9.Rigaku
10. DANI Instruments
11.LECO
12. SCIEX
13.Jeol Ltd

FAQs:

1. Who are the key players in the Mass Spectrometry market?
Ans. The Shimadzu Corporation, Agilent Technologies, PerkinElmer, Thermo Fisher Scientific, and Bruker are some of the market players in the Mass Spectrometry industry.

2. Which Application segment dominates the Mass Spectrometry market?
Ans. The Life Science Research segment accounted for the largest share of the global Mass Spectrometry market in 2022.

3. Which end-user segment of the global Mass Spectrometry market is expected to witness the highest growth?
Ans. The Pharmaceutical Companies segment accounted for the highest revenue share due to the rise of the pharmaceutical sector, and the existence of severe regulatory guidelines for drug development and safety.

4. How big is the Mass Spectrometry market?
Ans. The global Mass Spectrometry market size reached USD 5.78 billion in 2022 and is expected to reach USD 9.42 billion by 2029 Mass Spectrometry, growing at a CAGR of 7.2% during the forecast period.

5. What are the key regions in the global Mass Spectrometry market?
Ans. Based On the region, the market has been classified into North America, Europe, Asia Pacific, Middle, East and Africa, and Latin America. North America dominates the global Mass Spectrometry market.